Company profile IMNN
There is not enough data for immunotherapies and vaccines to provide analysis
There is not enough data for immunotherapies and vaccines to provide correlation calculation
There is not enough data for immunotherapies and vaccines to provide analysis
There is not enough data for IMNN-001 to provide analysis
There is not enough data for IMNN-001 to provide correlation calculation
There is not enough data for IMNN-001 to provide analysis
There is not enough data for Phase II clinical development to provide analysis
There is not enough data for Phase II clinical development to provide correlation calculation
There is not enough data for Phase II clinical development to provide analysis
After 39 days of this quarter the interest is at 17.0. Based on that we can calculate that during remaining 52 days it will total up to 40.0. ThermoDox expected interest is significantly lower compared to same quarter last year (-50.6%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 156 | 114 -26.9% QoQ | 87 -23.7% QoQ | 0 -100.0% QoQ |
| 2020 | 69 -55.8% YoY inf% QoQ | 106 -7.0% YoY 53.6% QoQ | 75 -13.8% YoY -29.2% QoQ | 54 inf% YoY -28.0% QoQ |
| 2021 | 39 -43.5% YoY -27.8% QoQ | 78 -26.4% YoY 100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 158 192.6% YoY inf% QoQ |
| 2022 | 142 264.1% YoY -10.1% QoQ | 58 -25.6% YoY -59.2% QoQ | 76 inf% YoY 31.0% QoQ | 135 -14.6% YoY 77.6% QoQ |
| 2023 | 81 -43.0% YoY -40.0% QoQ | 177 205.2% YoY 118.5% QoQ | 90 18.4% YoY -49.2% QoQ | 59 -56.3% YoY -34.4% QoQ |
| 2024 | 17 -79.0% YoY -71.2% QoQ | - | - | - |
The average 5 years interest of ThermoDox was 6.79 per week. The last year interest of ThermoDox compared to the last 5 years has changed by 11.63%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 10.33%.
After 39 days of this quarter the interest is at 331.0. Based on that we can calculate that during remaining 52 days it will total up to 772.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 524 | 827 57.8% QoQ | 838 1.3% QoQ | 816 -2.6% QoQ |
| 2020 | 816 55.7% YoY 0.0% QoQ | 752 -9.1% YoY -7.8% QoQ | 822 -1.9% YoY 9.3% QoQ | 775 -5.0% YoY -5.7% QoQ |
| 2021 | 806 -1.2% YoY 4.0% QoQ | 833 10.8% YoY 3.3% QoQ | 764 -7.1% YoY -8.3% QoQ | 757 -2.3% YoY -0.9% QoQ |
| 2022 | 882 9.4% YoY 16.5% QoQ | 863 3.6% YoY -2.2% QoQ | 810 6.0% YoY -6.1% QoQ | 753 -0.5% YoY -7.0% QoQ |
| 2023 | 918 4.1% YoY 21.9% QoQ | 860 -0.3% YoY -6.3% QoQ | 827 2.1% YoY -3.8% QoQ | 908 20.6% YoY 9.8% QoQ |
| 2024 | 331 -63.9% YoY -63.5% QoQ | - | - | - |
The average 5 years interest of hepatocellular carcinoma was 63.15 per week. The last year interest of hepatocellular carcinoma compared to the last 5 years has changed by 4.35%. The interest for hepatocellular carcinoma is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by 2.94%.
There is not enough data for TheraPlas platform to provide analysis
There is not enough data for TheraPlas platform to provide correlation calculation
There is not enough data for TheraPlas platform to provide analysis
There is not enough data for PLACCINE platform to provide analysis
There is not enough data for PLACCINE platform to provide correlation calculation
There is not enough data for PLACCINE platform to provide analysis
There is not enough data for nucleic acid-based therapies to provide analysis
There is not enough data for nucleic acid-based therapies to provide correlation calculation
There is not enough data for nucleic acid-based therapies to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. nucleic acid vaccines expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 88 | 176 100.0% QoQ | 82 -53.4% QoQ | 62 -24.4% QoQ |
| 2020 | 78 -11.4% YoY 25.8% QoQ | 144 -18.2% YoY 84.6% QoQ | 99 20.7% YoY -31.2% QoQ | 110 77.4% YoY 11.1% QoQ |
| 2021 | 116 48.7% YoY 5.5% QoQ | 73 -49.3% YoY -37.1% QoQ | 127 28.3% YoY 74.0% QoQ | 72 -34.5% YoY -43.3% QoQ |
| 2022 | 180 55.2% YoY 150.0% QoQ | 131 79.5% YoY -27.2% QoQ | 102 -19.7% YoY -22.1% QoQ | 31 -56.9% YoY -69.6% QoQ |
| 2023 | 204 13.3% YoY 558.1% QoQ | 31 -76.3% YoY -84.8% QoQ | 65 -36.3% YoY 109.7% QoQ | 298 861.3% YoY 358.5% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of nucleic acid vaccines was 8.69 per week. The last year interest of nucleic acid vaccines compared to the last 5 years has changed by 6.44%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 2.32%.
After 34 days of this quarter the interest is at 93.0. Based on that we can calculate that during remaining 58 days it will total up to 252.0. cancer expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+inf%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 1022 inf% YoY inf% QoQ | 1091 inf% YoY 6.8% QoQ |
| 2021 | 1082 inf% YoY -0.8% QoQ | 1104 inf% YoY 2.0% QoQ | 1130 10.6% YoY 2.4% QoQ | 1103 1.1% YoY -2.4% QoQ |
| 2022 | 866 -20.0% YoY -21.5% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 93 inf% YoY inf% QoQ |
The average 5 years interest of cancer was 28.81 per week. The last year interest of cancer compared to the last 5 years has changed by -93.79%. The interest for cancer is significantly decreasing. This didn't exist 5 years ago.
After 39 days of this quarter the interest is at 223.0. Based on that we can calculate that during remaining 52 days it will total up to 520.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 311 | 455 46.3% QoQ | 381 -16.3% QoQ | 411 7.9% QoQ |
| 2020 | 755 142.8% YoY 83.7% QoQ | 643 41.3% YoY -14.8% QoQ | 515 35.2% YoY -19.9% QoQ | 442 7.5% YoY -14.2% QoQ |
| 2021 | 433 -42.6% YoY -2.0% QoQ | 393 -38.9% YoY -9.2% QoQ | 373 -27.6% YoY -5.1% QoQ | 410 -7.2% YoY 9.9% QoQ |
| 2022 | 497 14.8% YoY 21.2% QoQ | 504 28.2% YoY 1.4% QoQ | 401 7.5% YoY -20.4% QoQ | 479 16.8% YoY 19.5% QoQ |
| 2023 | 521 4.8% YoY 8.8% QoQ | 492 -2.4% YoY -5.6% QoQ | 415 3.5% YoY -15.7% QoQ | 534 11.5% YoY 28.7% QoQ |
| 2024 | 223 -57.2% YoY -58.2% QoQ | - | - | - |
The average 5 years interest of infectious diseases was 36.74 per week. The last year interest of infectious diseases compared to the last 5 years has changed by 2.53%. The interest for infectious diseases is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 11.68%.